Exploring the links between systemic lupus erythematosus and cancer

Sasha Bernatsky, Rosalind Ramsey-Goldman, Ann Clarke*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

18 Scopus citations

Abstract

Recent data confirm that certain cancers, particularly hematologic, occur more frequently in SLE than in the general population. Numerous pathogenic mechanisms are possible, but hypotheses remain largely speculative. In particular, data are inadequate on how cancer risk in SLE may be related to medication exposures. To evaluate the impact of medication exposures on cancer risk in SLE, cooperative efforts of SLICC and CaNIOS are currently in progress. This should provide much-needed insight into the pathogenesis of the association between cancer and SLE.

Original languageEnglish (US)
Pages (from-to)387-402
Number of pages16
JournalRheumatic Disease Clinics of North America
Volume31
Issue number2
DOIs
StatePublished - May 2005

ASJC Scopus subject areas

  • Rheumatology

Fingerprint

Dive into the research topics of 'Exploring the links between systemic lupus erythematosus and cancer'. Together they form a unique fingerprint.

Cite this